Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017

American Journal of Preventive Medicine

Volumn 58, Issue 3, 2020, Pages 336-342

  Osei, Albert D ^a,b   Mirbolouk, Mohammadhassan ^a,b   Orimoloye, Olusola A ^a,b   Dzaye, Omar ^b,c   Uddin, S M Iftekhar ^a,b   Benjamin, Emelia J ^a,d   Hall, Michael E ^a,e   DeFilippis, Andrew P ^a,f   Bhatnagar, Aruni ^a,f   Biswal, Shyam S ^g   Blaha, Michael J ^a,b  

^a AMERICAN HEART ASSOCIATION   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f University of Louisville School of Medicine   (United States)

^g The Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPHYSEMA; EXPOSURE; FEMALE; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PEOPLE BY SMOKING STATUS; SELF REPORT; UNITED STATES; VAPING; CROSS-SECTIONAL STUDY; ELECTRONIC CIGARETTE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADULT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CROSS-SECTIONAL STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF REPORT; UNITED STATES; VAPING;

EID: 85079029694     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2019.10.014     Document Type: Article

References (29)

1. Mirbolouk, M, Charkhchi, P, Kianoush, S, et al. Prevalence and distribution of e-cigarette use among U.S. adults: Behavioral Risk Factor Surveillance System, 2016. Ann Intern Med 169:7 (2018), 429–438 https://doi.org/10.7326/M17-3440.
2. Bhatnagar, A, Whitsel, LP, Ribisl, KM, et al. Electronic cigarettes: a policy statement from the American Heart Association. Circulation 130:16 (2014), 1418–1436 https://doi.org/10.1161/CIR.0000000000000107.
3. Mirbolouk, M, Charkhchi, P, Orimoloye, OA, et al. E-cigarette use without a history of combustible cigarette smoking among U.S. adults: Behavioral Risk Factor Surveillance System, 2016. Ann Intern Med 170:1 (2019), 76–79 https://doi.org/10.7326/M18-1826.
4. Qasim, H, Karim, ZA, Rivera, JO, Khasawneh, FT, Alshbool, FZ, Impact of electronic cigarettes on the cardiovascular system. J Am Heart Assoc, 6(9), 2017, e006353 https://doi.org/10.1161/JAHA.117.006353.
5. Grana, R, Benowitz, N, Glantz, SA, E-cigarettes: a scientific review. Circulation 129:19 (2014), 1972–1986 https://doi.org/10.1161/CIRCULATIONAHA.114.007667.
6. Chun, LF, Moazed, F, Calfee, CS, Matthay, MA, Gotts, JE, Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol 313:2 (2017), L193–L206 https://doi.org/10.1152/ajplung.00071.2017.
7. Glantz, SA, Bareham, DW, E-cigarettes: use, effects on smoking, risks, and policy implications. Annu Rev Public Health 39 (2018), 215–235 https://doi.org/10.1146/annurev-publhealth-040617-013757.
8. Garcia-Arcos, I, Geraghty, P, Baumlin, N, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 71:12 (2016), 1119–1129 https://doi.org/10.1136/thoraxjnl-2015-208039.
9. Sussan, TE, Gajghate, S, Thimmulappa, RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One, 10(2), 2015, e0116861 https://doi.org/10.1371/journal.pone.0116861.
10. Lerner, CA, Sundar, IK, Yao, H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One, 10(2), 2015, e0116732 https://doi.org/10.1371/journal.pone.0116732.
11. Martin, EM, Clapp, PW, Rebuli, ME, et al. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol Lung Cell Mol Physiol 311:1 (2016), L135–L144 https://doi.org/10.1152/ajplung.00170.2016.
12. Hwang, JH, Lyes, M, Sladewski, K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med (Berl) 94:6 (2016), 667–679 https://doi.org/10.1007/s00109-016-1378-3.
13. Wills, TA, Pagano, I, Williams, RJ, Tam, EK, E-cigarette use and respiratory disorder in an adult sample. Drug Alcohol Depend 194 (2019), 363–370 https://doi.org/10.1016/j.drugalcdep.2018.10.004.
14. National Academies of sciences, engineering, and medicine. Public Health Consequences of E-Cigarettes. 2018, The National Academies Press, Washington, DC.
15. McConnell, R, Barrington-Trimis, JL, Wang, K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med 195:8 (2017), 1043–1049 https://doi.org/10.1164/rccm.201604-0804OC.
16. Hedman, L, Backman, H, Stridsman, C, et al. Association of electronic cigarette use with smoking habits, demographic factors, and respiratory symptoms. JAMA Netw Open, 1(3), 2018, e180789 https://doi.org/10.1001/jamanetworkopen.2018.0789.
17. Perez, MF, Atuegwu, NC, Mead, EL, Oncken, C, Mortensen, EM, Adult e-cigarettes use associated with a self-reported diagnosis of COPD. Int J Environ Res Public Health, 16(20), 2019, 3938 https://doi.org/10.3390/ijerph16203938.
18. CDC. About BRFSS. www.cdc.gov/brfss/about/index.htm. Accessed August 22, 2018.
19. CDC. Behavioral Risk Factor Surveillance System 2016 Summary Data Quality Report. Published 2017 www.cdc.gov/brfss/annual_data/2016/pdf/2016-sdqr.pdf. (Accessed 26 September 2018)
20. CDC. The Behavioral Risk Factor Surveillance System 2017 Summary Data Quality Report. Published 2018 www.cdc.gov/brfss/annual_data/2017/pdf/2017-sdqr-508.pdf. (Accessed 26 September 2018)
21. Federal Register. Annual Update of the HHS Poverty Guidelines. Published 2017 www.federalregister.gov/documents/2017/01/31/2017-02076/annual-update-of-the-hhs-poverty-guidelines. (Accessed 1 October 2018)
22. CDC. Behavioral Risk Factor Surveillance System: weighting BRFSS data, BRFSS 2016. Published 2016 www.cdc.gov/brfss/annual_data/2016/pdf/weighting_the-data_webpage_content.pdf. (Accessed 30 August 2018)
23. Reidel, B, Radicioni, G, Clapp, PW, et al. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 197:4 (2018), 492–501 https://doi.org/10.1164/rccm.201708-1590OC.
24. Lundbäck, B, Lindberg, A, Lindström, M, et al. Not 15 but 50% of smokers develop COPD?–Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 97:2 (2003), 115–122 https://doi.org/10.1053/rmed.2003.1446.
25. Wang, MP, Ho, SY, Leung, LT, Lam, TH, Electronic cigarette use and respiratory symptoms in Chinese adolescents in Hong Kong. JAMA Pediatr 170:1 (2016), 89–91 https://doi.org/10.1001/jamapediatrics.2015.3024.
26. Cho, JH, Paik, SY, Association between electronic cigarette use and asthma among high school students in South Korea. PLoS One, 11(3), 2016, e0151022 https://doi.org/10.1371/journal.pone.0151022.
27. Kamil, F, Pinzon, I, Foreman, MG, Sex and race factors in early-onset COPD. Curr Opin Pulm Med 19:2 (2013), 140–144 https://doi.org/10.1097/MCP.0b013e32835d903b.
28. Aryal, S, Diaz-Guzman, E, Mannino, DM, COPD and gender differences: an update. Transl Res 162:4 (2013), 208–218 https://doi.org/10.1016/j.trsl.2013.04.003.
29. HHS, Food and Drug Administation. Restrictions on the sale and distribution of tobacco products and required warning statements for tobacco products; final rule. Fed Regist, 90(81), 2016 www.gpo.gov/fdsys/pkg/FR-2016-05-10/pdf/2016-10685.pdf. (Accessed 31 October 2018)